OpenAlex
PricingAboutJobs
Log inGet started
Work

The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats

HTML

Year: 2010
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/j.1463-1326.2010.01291.x
Authors: F. R. Macdonald, J. E. Peel, H. B. Jones, R. M. Mayers, L. Westgate, J. M. Whaley, S. M. Poucher
Institutions: AstraZeneca (United Kingdom), Bristol-Myers Squibb (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: dapagliflozin, SGLT2 inhibitors, type 2 diabetes, beta-cell function, islet morphology, beta-cell mass, insulin sensitivity, disposition index, hyperglycemia, obesity, Zucker diabetic fatty rats, high-fat diet, HbA1c, blood glucose reduction, beta-cell adaptation, hyperglycaemic clamp
SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, European Association for the Study of Diabetes
OpenAlex ID: W2148958160
FWCI: 3.744
Cites: 39
Cited by: 91
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security